80 results on '"Le Pavec, Jérôme"'
Search Results
2. Rapport 23–27. Transplantation pulmonaire de l’adulte en France, état des lieux
3. Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation
4. Molecular monitoring of lung allograft health: is it ready for routine clinical use?
5. Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis
6. 2022 Update of indications and contraindications for lung transplantation in France
7. Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease
8. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
9. Intimal Granulomatous Angiitis in Sarcoid Pulmonary Vasculitis: Worth Remembering
10. Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France
11. Evaluación multiparamétrica de la función ventricular derecha en la hipertensión arterial pulmonar asociada a cardiopatías congénitas
12. Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
13. Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study
14. Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation
15. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
16. Lung transplantation in HIV-positive patients: a European retrospective cohort study
17. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G
18. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort
19. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
20. Lung transplantation for acute respiratory distress syndrome – a retrospective European Cohort Study
21. Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension
22. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements
23. Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program
24. Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study
25. Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation
26. Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism
27. Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impact of current therapeutic approach including a high-priority allocation programme on outcomes
28. Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France
29. Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure
30. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study
31. Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection
32. Lung transplantation for sarcoidosis: outcome and prognostic factors
33. Can radiation-recall predict long lasting response to immune checkpoint inhibitors?
34. Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
35. Pulmonary Arterial Hypertension Complicating Connective Tissue Disorders
36. Late Limited Systemic Sclerosis Patient Who Develops Shortness of Breath on Exertion
37. Correspondence on ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’
38. Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study
39. Anakinra for severe forms of COVID-19: a cohort study
40. Lung transplantation for idiopathic pulmonary fibrosis
41. The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study
42. Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation
43. Impact of donor, recipient and matching on survival after high emergency lung transplantation in France
44. Pregnancy after lung and heart–lung transplantation: a French multicentre retrospective study of 39 pregnancies
45. Combined lung transplantation and percutaneous septal defect closure for end-stage atrial septal defect associated pulmonary arterial hypertension
46. The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
47. Heart-lung transplantation: current indications, prognosis and specific considerations
48. Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study
49. Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
50. Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.